Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Federal Trade Commission
Chinese Patent Office
AstraZeneca
Mallinckrodt
US Department of Justice
Teva
Argus Health

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,801,576

« Back to Dashboard

Summary for Patent: 4,801,576
Title: Method of inhibiting blood clotting with desulfatohirudins
Abstract:The present invention relates to desulfatohirudins, to the preparation thereof, to pharmaceutical compositions containing these compounds, and to the use thereof. The desulfatohirudins of this invention correspond to hirudin in biological activity and are therefore particularly useful for inhibiting blood clotting.
Inventor(s): Fritz; Hans (Hohenbrunn, DE), Dodt; Johannes (Munich, DE), Seemuller; Ursula (Munich, DE), Fink; Ernst (Westerstede-Giesselhorst, DE)
Assignee: Ciba-Geigy Corporation (Ardsley, NY)
Application Number:07/145,023
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 4,801,576

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,801,576

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3342139Nov 22, 1983

International Family Members for US Patent 4,801,576

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 165696 ➤ Try a Free Trial
Germany 3342139 ➤ Try a Free Trial
Germany 3483085 ➤ Try a Free Trial
Germany 19775096 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Johnson and Johnson
Fish and Richardson
McKinsey
Chinese Patent Office
QuintilesIMS
Citi
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.